CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 81 enrolled
Drug / intervention
Neuroblate Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05075850
NCT05075850N/ACompleted
CompareCT.gov

PatiEnt Neuropsychological outcomeS After laseR Ablation

Monteris Medical·observational·Posted Oct 13, 2021·Updated Apr 6, 2025

In Brief

An observational study evaluating Neuroblate System for Cognitive Change. Completed, enrolled 81 participants across 7 sites.

Detailed Summary

PatiEnt Neuropsychological outcomeS After laseR ablation

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCognitive Change
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedOct 13, 2021
Enrollment StartSep 29, 2021
Primary CompletionSep 30, 2023
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 4.7 years ago

Interventions

Neuroblate Systemdevice

All subjects will undergo comprehensive neuropsychological assessment post-LITT per standard of care practice. Visual field testing will be conducted in a subset of enrolled patients.